Marson AG - Search Results

1

A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.

Rädisch S, Dickens D, Lang T, Bonnett L, Arlanov R, Johnson MR, Schwab M, Marson AG, Pirmohamed M. Rädisch S, et al. Among authors: marson ag. Pharmacogenomics J. 2014 Oct;14(5):481-7. doi: 10.1038/tpj.2014.5. Epub 2014 Feb 25. Pharmacogenomics J. 2014. PMID: 24567120

2

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.

Gamble C, Williamson PR, Chadwick DW, Marson AG. Gamble C, et al. Among authors: marson ag. Neurology. 2006 May 9;66(9):1310-7. doi: 10.1212/01.wnl.0000210517.03902.6e. Neurology. 2006. PMID: 16682660 Review.

3

Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.

Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Rogers J, Bentley DR, Chadwick DW, Balding DJ, Johnson MR. Leschziner G, et al. Among authors: marson ag. Lancet Neurol. 2006 Aug;5(8):668-76. doi: 10.1016/S1474-4422(06)70500-2. Lancet Neurol. 2006. PMID: 16857572

4

The association between polymorphisms in RLIP76 and drug response in epilepsy.

Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, Chadwick D, Johnson MR, Pirmohamed M. Leschziner GD, et al. Among authors: marson ag. Pharmacogenomics. 2007 Dec;8(12):1715-22. doi: 10.2217/14622416.8.12.1715. Pharmacogenomics. 2007. PMID: 18086001

5

Effect of topiramate on acid-base balance: extent, mechanism and effects.

Mirza N, Marson AG, Pirmohamed M. Mirza N, et al. Among authors: marson ag. Br J Clin Pharmacol. 2009 Nov;68(5):655-61. doi: 10.1111/j.1365-2125.2009.03521.x. Br J Clin Pharmacol. 2009. PMID: 19916989 Free PMC article.

6

Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures.

Bonnett LJ, Tudur-Smith C, Williamson PR, Marson AG. Bonnett LJ, et al. Among authors: marson ag. BMJ. 2010 Dec 7;341:c6477. doi: 10.1136/bmj.c6477. BMJ. 2010. PMID: 21147743 Free PMC article. Clinical Trial.

7

Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.

Mirza NS, Alfirevic A, Jorgensen A, Marson AG, Pirmohamed M. Mirza NS, et al. Among authors: marson ag. Pharmacogenet Genomics. 2011 May;21(5):297-302. doi: 10.1097/FPC.0b013e3283441b95. Pharmacogenet Genomics. 2011. PMID: 21278619

8

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.

Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG. Bonnett L, et al. Among authors: marson ag. Lancet Neurol. 2012 Apr;11(4):331-40. doi: 10.1016/S1474-4422(12)70018-2. Epub 2012 Feb 28. Lancet Neurol. 2012. PMID: 22377180 Free article. Clinical Trial.

9

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.

Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A. Yip VL, et al. Among authors: marson ag. Clin Pharmacol Ther. 2012 Dec;92(6):757-65. doi: 10.1038/clpt.2012.189. Epub 2012 Nov 7. Clin Pharmacol Ther. 2012. PMID: 23132554 Review.

10

Immunomodulatory interventions for focal epilepsy syndromes.

Walker L, Pirmohamed M, Marson AG. Walker L, et al. Among authors: marson ag. Cochrane Database Syst Rev. 2013 Jun 27;(6):CD009945. doi: 10.1002/14651858.CD009945.pub2. Cochrane Database Syst Rev. 2013. PMID: 23803963 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page